Qilu Pharmaceutical, one of the leading pharmaceutical companies in China, develops, manufactures and markets quality and affordable generic drugs in some important therapeutic areas of Oncology, Infections, Cerebrovascular & Cardiovascular, Psychological and Neurological system, Respiratory system, Ophthalmological Diseases.


With strong R&D capability, the company developed and launched lots of branded generics in the last two decades, most of them are well-known with a high recognition among general public. A rich and expanding pipeline is integrated into the product portfolio that is the drive of steady and rapid growth of the company.


Besides a prosperous domestic market, Qilu is also actively registering its products with Drug Master File and Dossier in many countries. In response to increasing interest in products of China origin, the company is ready to provide Custom Manufacture to the customers with not only cost savings but also high quality.


The combination of technical know-how, state-of-the-art production facilities and integrated regulatory support provided by Qilu will be critical advantages for its customers in present competitive environment.